All Stories

  1. Barriers to access to clinical trial data: Obstruction of a RIAT reanalysis of the treatment for adolescents with depression study
  2. Data transparency in clinical trials: Implications of Restoring Study 329
  3. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression
  4. Deconstruction of Forest's CIT MD 19 citalopram trial for pediatric depression
  5. Medical Malpractice: Child and Adolescent Psychiatry
  6. Authors’ reply to Sasich and Linden
  7. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
  8. Let children cry
  9. Let children cry
  10. Inadequacy of remote desktop interface for independent reanalysis of data from drug trials
  11. Antidepressant Medication and Spontaneous Abortion
  12. Psychodynamic minimalism
  13. Transparency and accountability in early psychosis intervention research
  14. Combination Pharmacotherapy for Psychiatric Disorders in Children and Adolescents: Prevalence, Efficacy, Risks and Research Needs
  15. Inappropriate Data and Measures Lead to Questionable Conclusions
  16. Healthy Kids Check: Lack of transparency and misplaced faith in the benefits of screening
  17. Targeted primary care-based mental health services for young Australians
  18. Child and Adolescent Refugees and Asylum Seekers in Australia
  19. BRIDGE Study Warrants Critique
  20. Key opinion leaders in psychiatry: A conflicted pathway to career advancement
  21. Guidance offers little in the way of ethics or transparency
  22. Explanations and unexplanations: Restoring meaning to psychiatry
  23. Novel melatonin-based treatments for major depression
  24. Collusion of medical journal editors and pharmaceutical industry on ghostwriting
  25. 'Prodromal' diagnosis of psychosis: Ethical problems in research and clinical practice
  26. Diagnosis, Pathophysiology, and Management of Mood Disorders in Pregnant and Postpartum Women
  27. Children in immigration detention: a case of reckless mistreatment
  28. Aripiprazole in the Maintenance Treatment of Bipolar Disorder: A Critical Review of the Evidence and Its Dissemination into the Scientific Literature
  29. Conflicts of Interest in Medical Journals
  30. The increased use of antidepressants has contributed to the worldwide reduction in suicide rates
  31. Elsevier should divest itself of either its medical publishing or pharmaceutical services division
  32. How do we Safely Treat Depression in Children, Adolescents and Young Adults?
  33. Key Opinion Leaders and Paediatric Antidepressant Overprescribing
  34. NICE recommendations are not evidence based and could expose many to unnecessary harm
  35. The Rise and Fall of Roy Meadow
  36. Industry-Sponsored Ghostwriting in Clinical Trial Reporting: A Case Study
  37. Does Venlafaxine Maintenance Therapy Prevent Depression Recurrences or Drug Discontinuation Reactions?
  38. Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?
  39. The Black Box Warning: Decreased Prescriptions and Increased Youth Suicide?
  40. Study was not a trial of antidepressants
  41. Educating Health Professionals about Drug and Device Promotion: Advocates' Recommendations
  42. Engagement with health and social care services: perceptions of homeless young people with mental health problems
  43. Response
  44. Self-management of medication for mental health problems by homeless young people
  45. An interdisciplinary course for trainee psychiatrists: feedback and implications
  46. Overuse of Antidepressant Drugs for the Treatment of Depression
  47. An interdisciplinary course for trainee psychiatrists: feedback and implications
  48. Suicide and antidepressants in children
  49. Wishful thinking: antidepressant drugs in childhood depression
  50. Partnerships between academic psychiatry and the pharmaceutical industry.
  51. CORRESPONDENCE: 1
  52. MEDICAL MALPRACTICE | Child and Adolescent Psychiatry
  53. Does Dissociation Offer a Useful Explanation for Psychopathology?
  54. TADS study raises concerns
  55. Psychiatric assessment of children and families in immigration detention - clinical, administrative and ethical issues
  56. Correspondence
  57. Narrative and Coherence
  58. Efficacy and safety of antidepressants for children and adolescents
  59. Parenting capacity
  60. The statin wars
  61. PAROXETINE IN MAJOR DEPRESSION
  62. Concerns about research and prevention strategies in Munchausen Syndrome by Proxy (MSBP) abuse
  63. Hysteria
  64. Dispensing With the Dynamic Unconscious
  65. The Last Rites of the Dynamic Unconscious
  66. Child Abuse Specific to the Medical System
  67. Does drug promotion adversely influence doctors' abilities to make the best decisions for patients?
  68. Perversion: Erotic Form of Hatred or Exciting Avoidance of Reality?
  69. Delusion, Rationality, Empathy: Commentary on Martin Davies et al.:
  70. Pathological Play
  71. What is in an unconscious?
  72. Some reasons for concern about attention deficit hyperactivity disorder
  73. Munchausen syndrome by proxy.
  74. Obstetric Factitious Disorder and Munchausen Syndrome by Proxy
  75. Rehabilitation of young adolescents severely disabled after psychosis: A clinical study.
  76. Projective identification in general psychiatry
  77. 13. Patient voice: including the patient in mental health handovers
  78. 12. Maintaining and generating knowledge in interprofessional mental health handovers
  79. Review of the evidence for management of unexplained signs and symptoms in children and its relation to the south Australian context